PCI Biotech file patents for combination of siRNA and the PCI technology
21-Mar-2007
Kjetil Hestdal, President and CEO of Photocure, says: "Achieving safe and efficient gene delivery in the body has been a major limiting factor in the development of gene therapy. Our goal is to develop an effective treatment of cancer therapy through the combination of siRNA and the PCI technology."
Most read news
Other news from the department research and development
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.